Impact of drug development on the use of stem cell transplantation. A report by the activity survey of the European Society for Blood and Marrow Transplantatio (EBMT)

Clinical development of gene- and cell-based therapies: overview of the European landscape

Sofieke de Wilde
Henk-Jan Guchelaar
Maarten Laurens Zandvliet
Pauline Meij

January 2016

In the last decade, many clinical trials with gene- and cell-based therapies were performed and incr...

Development of a cell-based medicinal product: regulatory structures in the European

Beatriz Clares
Abdelkrim Hmadcha
Adolfina Ruiz
Bernat Soria

September 2016

Introduction: New therapies with genes, tissues and cells have taken the emerging field for the trea...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
de Latour, Régis Peffault
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

January 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT)

Passweg J. R.
Baldomero H.
Bader P.
Bonini C.
Cesaro S.
Dreger P.
Duarte R. F.
Dufour C.
Kuball J.
Farge-Bancel D.
Gennery A.
Kroger N.
Lanza F.
Nagler A.
Sureda A.
Mohty M.

January 2017

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 0...

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

Passweg, J. R
Baldomero, H
Bader, P
Bonini, C
Dreger, P
Duarte, R. F
Dufour, C
Kuball, J
Farge Bancel, D
Gennery, A
Kröger, N
Lanza, F
Nagler, A
Sureda, A
Mohty, M.
CESARO, SIMONE

January 2017

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 0...

Impact of drug development on the use of stem cell transplantation : a report by the European Society for Blood and Marrow Transplantation (EBMT)

Passweg, J R
Baldomero, H
Bader, P
Bonini, C
Cesaro, S
Dreger, P
Duarte, R F
Dufour, C
Kuball, J
Farge-Bancel, D
Gennery, A
Kröger, N
Lanza, F
Nagler, A
Sureda, A
Mohty, M

January 2017

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 0...

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Passweg, Jakob,
Baldomero, Helen
Chabannon, Christian
Basak, Grzegorz
de La Cámara, Rafael
Corbacioglu, Selim
Dolstra, Harry
Duarte, Rafael
Glass, Bertram
Greco, Raffaella
Lankester, Arjan
Mohty, Mohamad
Peffault de Latour, Régis
Snowden, John,
Yakoub-Agha, Ibrahim
Kröger, Nicolaus

February 2021

International audienceNumbers of Hematopoietic cell transplantation (HCT) in Europe and collaboratin...

Impact of the European clinical trials directive on prospective academic clinical trials associated with BMT.

Frewer, LJ
Coles, D
van der Lans, IA
Schroeder, D
Champion, K
Apperley, JF

March 2011

The European Clinical Trials Directive (EU 2001; 2001/20/EC) was introduced to improve the efficienc...

Impact of the European Clinical Trials Directive on prospective academic clinical trials associated with BMT

Frewer, L.J.
Coles, D.G.
Lans, I.A., van der
Schroeder, D.
Champion, K.
Apperley, J.F.

January 2011

The European Clinical Trials Directive (EU 2001; 2001/20/EC) was introduced to improve the efficienc...

The EBMT activity survey 2006 on hematopoietic stem cell transplantation : focus on the use of cord blood products

Gratwohl, A.
Baldomero, H.
Frauendorfer, K.
Rocha, V.
Apperley, J.
Niederwieser, D.
Joint, Accreditation Committee of the International Society for Cellula
European, Group for Blood
Marrow, Transplantation Ebmt

January 2008

This report describes the hematopoietic stem cell transplantation (HSCT) activity in Europe in 2006 ...

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Trounson, Alan
McDonald, Courtney

July 2015

Clinical investigations using stem cell products in regenerative medicine are addressing a wide spec...

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Passweg, J.R.
Baldomero, H.
Chabannon, C.
Basak, G.W.
Corbacioglu, S.
Duarte, R.
Dolstra, H.
Lankester, A.C.
Mohty, M.
Montoto, S.
Latour, R.P. de
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Kroger, N.
European Soc Blood Marrow Transpla

February 2020

Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus

Passweg, Jakob, R
Baldomero, Helen
Chabannon, Christian
Basak, Grzegorz, W
Corbacioglu, Selim
Duarte, Rafael
Dolstra, Harry
Lankester, Arjan, C
Mohty, Mohamad
Montoto, Silvia
Peffault de Latour, Régis
Snowden, John, A
Styczynski, Jan
Yakoub-Agha, Ibrahim
Kröger, Nicolaus

February 2020

International audienceHematopoietic-cell transplantation (HCT) is widely used for acquired and conge...

The EBMT activity survey report 2017 : a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

European Society for Blood and Marrow Transplantation (EBMT)

October 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Passweg, J.R.
Baldomero, H.
Basak, G.W.
Chabannon, C.
Corbacioglu, S.
Duarte, R.
Kuball, J.
Lankester, A.
Montoto, S.
de Latour, R.P.
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Arat, M.
Mohty, M.
Kröger, N.
European Society for Blood and Marrow Transplantation (EBMT), EBMT

February 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Clinical development of gene- and cell-based therapies: overview of the European landscape

Sofieke de Wilde
Henk-Jan Guchelaar
Maarten Laurens Zandvliet
Pauline Meij

January 2016

In the last decade, many clinical trials with gene- and cell-based therapies were performed and incr...

Development of a cell-based medicinal product: regulatory structures in the European

Beatriz Clares
Abdelkrim Hmadcha
Adolfina Ruiz
Bernat Soria

September 2016

Introduction: New therapies with genes, tissues and cells have taken the emerging field for the trea...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
de Latour, Régis Peffault
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

January 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT)

Passweg J. R.
Baldomero H.
Bader P.
Bonini C.
Cesaro S.
Dreger P.
Duarte R. F.
Dufour C.
Kuball J.
Farge-Bancel D.
Gennery A.
Kroger N.
Lanza F.
Nagler A.
Sureda A.
Mohty M.

January 2017

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 0...

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

Passweg, J. R
Baldomero, H
Bader, P
Bonini, C
Dreger, P
Duarte, R. F
Dufour, C
Kuball, J
Farge Bancel, D
Gennery, A
Kröger, N
Lanza, F
Nagler, A
Sureda, A
Mohty, M.
CESARO, SIMONE

January 2017

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 0...

Impact of drug development on the use of stem cell transplantation : a report by the European Society for Blood and Marrow Transplantation (EBMT)

Passweg, J R
Baldomero, H
Bader, P
Bonini, C
Cesaro, S
Dreger, P
Duarte, R F
Dufour, C
Kuball, J
Farge-Bancel, D
Gennery, A
Kröger, N
Lanza, F
Nagler, A
Sureda, A
Mohty, M

January 2017

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 0...

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Passweg, Jakob,
Baldomero, Helen
Chabannon, Christian
Basak, Grzegorz
de La Cámara, Rafael
Corbacioglu, Selim
Dolstra, Harry
Duarte, Rafael
Glass, Bertram
Greco, Raffaella
Lankester, Arjan
Mohty, Mohamad
Peffault de Latour, Régis
Snowden, John,
Yakoub-Agha, Ibrahim
Kröger, Nicolaus

February 2021

International audienceNumbers of Hematopoietic cell transplantation (HCT) in Europe and collaboratin...

Impact of the European clinical trials directive on prospective academic clinical trials associated with BMT.

Frewer, LJ
Coles, D
van der Lans, IA
Schroeder, D
Champion, K
Apperley, JF

March 2011

The European Clinical Trials Directive (EU 2001; 2001/20/EC) was introduced to improve the efficienc...

Impact of the European Clinical Trials Directive on prospective academic clinical trials associated with BMT

Frewer, L.J.
Coles, D.G.
Lans, I.A., van der
Schroeder, D.
Champion, K.
Apperley, J.F.

January 2011

The European Clinical Trials Directive (EU 2001; 2001/20/EC) was introduced to improve the efficienc...

The EBMT activity survey 2006 on hematopoietic stem cell transplantation : focus on the use of cord blood products

Gratwohl, A.
Baldomero, H.
Frauendorfer, K.
Rocha, V.
Apperley, J.
Niederwieser, D.
Joint, Accreditation Committee of the International Society for Cellula
European, Group for Blood
Marrow, Transplantation Ebmt

January 2008

This report describes the hematopoietic stem cell transplantation (HSCT) activity in Europe in 2006 ...

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Trounson, Alan
McDonald, Courtney

July 2015

Clinical investigations using stem cell products in regenerative medicine are addressing a wide spec...

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Passweg, J.R.
Baldomero, H.
Chabannon, C.
Basak, G.W.
Corbacioglu, S.
Duarte, R.
Dolstra, H.
Lankester, A.C.
Mohty, M.
Montoto, S.
Latour, R.P. de
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Kroger, N.
European Soc Blood Marrow Transpla

February 2020

Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus

Passweg, Jakob, R
Baldomero, Helen
Chabannon, Christian
Basak, Grzegorz, W
Corbacioglu, Selim
Duarte, Rafael
Dolstra, Harry
Lankester, Arjan, C
Mohty, Mohamad
Montoto, Silvia
Peffault de Latour, Régis
Snowden, John, A
Styczynski, Jan
Yakoub-Agha, Ibrahim
Kröger, Nicolaus

February 2020

International audienceHematopoietic-cell transplantation (HCT) is widely used for acquired and conge...

The EBMT activity survey report 2017 : a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

European Society for Blood and Marrow Transplantation (EBMT)

October 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Passweg, J.R.
Baldomero, H.
Basak, G.W.
Chabannon, C.
Corbacioglu, S.
Duarte, R.
Kuball, J.
Lankester, A.
Montoto, S.
de Latour, R.P.
Snowden, J.A.
Styczynski, J.
Yakoub-Agha, I.
Arat, M.
Mohty, M.
Kröger, N.
European Society for Blood and Marrow Transplantation (EBMT), EBMT

February 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Clinical development of gene- and cell-based therapies: overview of the European landscape

Sofieke de Wilde
Henk-Jan Guchelaar
Maarten Laurens Zandvliet
Pauline Meij

January 2016

In the last decade, many clinical trials with gene- and cell-based therapies were performed and incr...

Development of a cell-based medicinal product: regulatory structures in the European

Beatriz Clares
Abdelkrim Hmadcha
Adolfina Ruiz
Bernat Soria

September 2016

Introduction: New therapies with genes, tissues and cells have taken the emerging field for the trea...

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Passweg, Jakob R.
Baldomero, Helen
Basak, Grzegorz W.
Chabannon, Christian
Corbacioglu, Selim
Duarte, Rafael
Kuball, Jürgen
Lankester, Arjan
Montoto, Silvia
de Latour, Régis Peffault
Snowden, John A.
Styczynski, Jan
Yakoub-Agha, Ibrahim
Arat, Mutlu
Mohty, Mohamad
Kröger, Nicolaus

January 2019

Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital disorders of the...

Impact of drug development on the use of stem cell transplantation. A report by the activity survey of the European Society for Blood and Marrow Transplantatio (EBMT)

Abstract

Extracted data

Impact of drug development on the use of stem cell transplantation. A report by the activity survey of the European Society for Blood and Marrow Transplantatio (EBMT)

Abstract

Extracted data

Related items

Related items